Literature DB >> 23440571

Lymphoepithelioma-like gastric carcinoma: an unusual consequence of Epstein-Barr virus infection in an HIV-infected woman.

P Paniz-Mondolfi1, Y Pang, S Cohen, J Balderacchi, L Tsveniashvili, B Polsky, E M Sordillo.   

Abstract

Lymphoepithelioma-like-gastric carcinoma (LEL-GC) is an Epstein-Barr virus (EBV)-associated neoplasm of the stomach reported to have a better prognosis than conventional gastric adenocarcinoma. Unlike other EBV-associated malignancies, particularly lymphoproliferative disorders and undifferentiated nasopharyngeal carcinoma, for which risk has been shown to increase in human immunodeficiency virus (HIV) infection, LEL-GC remains rare; only one HIV-infected patient with LEL-GC has been reported previously. We describe an aggressive case of EBV-associated LEL-GC in a woman co-infected with HIV 1 and hepatitis C virus. In situ hybridization of an endoscopic biopsy specimen for EBV-encoded small RNA confirmed the presence of this agent exclusively in the gastric cancer cells. Our patient had recently started antiretroviral therapy, suggesting that immune reconstitution may have been a factor in presentation of this tumour.

Entities:  

Keywords:  AIDS; EBV; Epstein–Barr virus; HIV; lymphoepithelioma-like gastric carcinoma; malignancy

Mesh:

Substances:

Year:  2013        PMID: 23440571     DOI: 10.1258/ijsa.2012.012131

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  2 in total

1.  Computed tomography findings for a gastric lymphoepithelioma-like carcinoma: How often does it present as a submucosal mass?

Authors:  Cherry Kim; Hyun Jin Kim; Da Hye Son; Young Soo Park; Seong Ho Park; Jong Seok Lee; Ah Young Kim; Hyun Kwon Ha
Journal:  Eur Radiol       Date:  2015-12-01       Impact factor: 5.315

2.  Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patients.

Authors:  F Falasca; P Maida; A Gaeta; S Verzaro; I Mezzaroma; A Fantauzzi; G Donato; E Bonci; C Castilletti; G Antonelli; O Turriziani
Journal:  Infection       Date:  2014-10-18       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.